Revealing a significant insider sell on May 1, Peter J Wilkinson, SVP at Laboratory Corp (NYSE:LH), as per the latest SEC filing.
What Happened: Wilkinson's decision to sell 2,439 shares of Laboratory Corp was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is $498,358.
In the Thursday's morning session, Laboratory Corp's shares are currently trading at $199.78, experiencing a down of 0.76%.
Get to Know Laboratory Corp Better
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Financial Milestones: Laboratory Corp's Journey
Positive Revenue Trend: Examining Laboratory Corp's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.57% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower ...